Exclusive: Half of PCTs fail on antipsychotic prescribing

Over half of PCTs in England are failing to commission services to reduce antipsychotic prescribing among dementia patients, despite well-known safety risks, GP newspaper can reveal.

GPs have previously warned they are forced to prescribe the drugs because of a lack of alternative services to refer to
GPs have previously warned they are forced to prescribe the drugs because of a lack of alternative services to refer to

The findings increase pressure on the DoH to release its antipsychotics review, originally expected in spring.

Responses from 62 PCTs to a request for information by GP newspaper show 57% are failing to offer services to help GPs cut prescribing of the drugs risperidone and olanzapine.

Results of GP newspaper investigation

GPs have previously warned they are forced to prescribe the drugs, which can triple the risk of stroke and double the risk of death, because of a lack of alternative services to refer to.

The responses also show half of PCTs do not carry out audits recommended by NICE to find dementia patients suitable for treatment with acetyl-cholinesterase inhibitors, such as donepezil, rivastigmine and galantamine.

Alzheimer's Society chief executive Neil Hunt said: ‘It is a sad day when prescribing of antipsychotics is unacceptably high and prescriptions of cholinesterase inhibitors are among the lowest in Europe.

‘We must develop health and social care services that can respond to the challenge of dementia.'

North Shields GP, Dr Dave Tomson, who has an interest in mental health, said: ‘Most people now know antipsychotic prescribing is not desirable, but it still happens because of a lack of alternatives.

‘PCTs could incentivise GPs to take regular audits and reviews of antipsychotic prescribing.'

He called for better teamwork between psychiatrists, nursing homes, GPs and specialist practitioners.

A DoH spokeswoman said the anti-psychotic review would be published in November. Only ‘severely distressed' dementia patients or those putting themselves or others at risk should receive the drugs, she said.

Neil Durham

GP Online recommends

Alzheimer's Society

Read more

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

The RCGP and the Royal Pharmaceutical Society have called on GP practices and community...

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments have risen rapidly in recent weeks as schools returned, according...

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

Medical training and the future NHS workforce could be seriously damaged by the financial...

GPonline's news editor wins medical journalism award

GPonline's news editor wins medical journalism award

GPonline news editor Nick Bostock has won News Story of the Year (specialist media)...

How GPs can support patients with 'long COVID'

How GPs can support patients with 'long COVID'

GPs must be ready to support patients with physical, psychological and social problems...

BMA demands 'rule of six' overhaul to prevent further lockdowns

BMA demands 'rule of six' overhaul to prevent further lockdowns

The government must scrap its high-risk ‘rule of six’ and introduce more stringent...